# 📋 Multi-Agent Blackboard: Clinical Decision Tree Induction (Task 1.1)

This shared blackboard serves as the live working memory and turn-by-turn dialogue log for:
1. **Clinical Oncology Oracle**: Queries EAU/ESMO guidelines via ChromaDB to propose evidence-backed splitting rules.
2. **Empirical Gini Evaluator**: Evaluates candidate splits strictly on the training partition (`split == 'train'`, N=45) and calculates Delta Gini.
3. **Consolidator & Arbiter**: Manages tree topology, enforces patience budget (k=3), determines early stopping, and directs agent actions.

---

<!-- SECTION: human_guidance -->
# [R] ROLE
You are a senior consulting specialist in Urological Oncology and Evidence-Based Medicine, with comprehensive mastery of international prostate cancer guidelines (European Association of Urology - EAU, and ESMO).

# [C] CONTEXT
You are assessing an outpatient clinical cohort evaluated for suspected or monitored prostate disease. You have full access to international guidelines via ChromaDB (`query_clinical_literature`) and each patient is characterized strictly by the 10 official Ground Truth clinical variables evaluated for diagnostic relevance in Task 1:

### Extensive Clinical Profiles of the 10 Ground Truth Variables:
1. `radiology_report__pirads` (mpMRI PI-RADS v2.1 Score, Scale 1 to 5):
   - Biological meaning: Standardized assessment of the probability of clinically significant prostate cancer (csPCa, Gleason score >= 7 / ISUP grade group >= 2) in suspicious intraprostatic lesions on multiparametric MRI.
   - Use in clinical practice: Primary anatomical triaging tool. PI-RADS 1-2 indicates very low likelihood of aggressive malignancy; PI-RADS 3 represents indeterminate / equivocal findings; PI-RADS 4-5 indicates high to very high probability of invasive malignancy. Used to determine whether invasive biopsy is indicated or can be safely omitted/deferred.

2. `radiology_report__psa_density` (PSA Density - PSAD, ng/ml/cc):
   - Biological meaning: Ratio of serum total PSA to prostate gland volume measured by imaging (Total PSA / Prostate Volume).
   - Use in clinical practice: Corrects serum PSA for benign prostatic hyperplasia (BPH) volume enlargement. Malignant epithelial tissue secretes substantially more PSA per unit of volume than benign hyperplastic tissue. Key clinical discriminator in intermediate or indeterminate cases (especially PI-RADS 3) and active surveillance, distinguishing benign enlargement from aggressive disease.

3. `structured_prompt__bx` (Histopathological Finding of Prior Prostate Biopsies):
   - Biological meaning: Documented histological tissue diagnosis resulting from prior prostate core needle biopsies ('Positive' for confirmed adenocarcinoma, 'Negative' for benign/negative cores, or missing/naive).
   - Use in clinical practice: Crucial for determining whether a new biopsy is diagnostically necessary to establish a primary cancer diagnosis, whether it is redundant because malignancy is already histologically proven (guiding directly to definitive curative therapy), or whether re-biopsy is needed due to rising suspicion despite prior negative cores.

4. `laboratory_results__psa` (Total Serum PSA, ng/ml):
   - Biological meaning: Glycoprotein kallikrein enzyme synthesized by prostate luminal epithelial cells; bloodstream concentrations rise following basement membrane disruption.
   - Use in clinical practice: Primary biochemical screening and disease monitoring biomarker. Levels > 4.0 ng/ml indicate elevated risk of pathology (BPH, prostatitis, or malignancy); markedly high levels (> 10.0 or > 20.0 ng/ml) significantly increase the probability of high-grade, aggressive disease.

5. `structured_prompt__age` (Chronological Age, Years):
   - Biological meaning: Patient chronological age, acting as a direct surrogate for life expectancy and cumulative medical comorbidity.
   - Use in clinical practice: Urological guidelines apply the 10-year life expectancy benchmark. In elderly patients with limited life expectancy, diagnostic biopsy is frequently omitted to prevent overdiagnosis and overtreatment of indolent, non-lethal tumors that would never affect survival.

6. `structured_prompt__dre` (Digital Rectal Examination - DRE):
   - Biological meaning: Physical digital palpation of the posterior and lateral peripheral zones of the prostate gland ('Normal', 'Nodus', 'Suspicious', 'Not done').
   - Use in clinical practice: Detection of a palpable firm induration or nodule (clinical stage >= cT2) is an independent clinical predictor of aggressive cancer, representing a classical biopsy indication even when PSA is borderline or normal.

7. `clinical_data__family_history` (Family History of Prostate Cancer):
   - Biological meaning: Documented confirmed history of prostate cancer in first-degree relatives (father, brothers) or hereditary syndromes (BRCA1/2).
   - Use in clinical practice: Confers a 2- to 4-fold higher relative risk of developing prostate cancer, frequently associated with earlier onset or more aggressive phenotypes, lowering the clinical threshold for recommending imaging and diagnostic biopsy.

8. `clinical_data__cspca` (Algorithmic Risk Estimate of csPCa, 0.0 to 1.0):
   - Biological meaning: Continuous probabilistic score generated by multivariable risk calculators or machine learning models predicting clinically significant prostate cancer.
   - Use in clinical practice: Quantitative decision-support adjunct used to communicate individualized risk and facilitate shared clinical decision-making.

9. `radiology_report__prostate_volume` (Prostate Gland Volume by Imaging, cc):
   - Biological meaning: Anatomical volume of the prostate gland estimated via ultrasound or mpMRI.
   - Use in clinical practice: Quantifies the degree of benign enlargement (BPH). Markedly enlarged prostates (> 60-80 cc) frequently produce elevated total serum PSA purely from benign transitional zone tissue, explaining discrepancies between high PSA and low cancer risk.

10. `previous_notes__prior_cancer_confirmed` (Documented Previous Cancer Diagnosis, 1=Yes, 0=No):
    - Biological meaning: Formal binary medical record entry confirming a previous clinical diagnosis of prostate neoplasia.
    - Use in clinical practice: Identifies patients who are not in the primary diagnostic pathway but rather in active surveillance, watchful waiting, or post-treatment follow-up, where repeating an invasive biopsy requires explicit justification of clinical or radiological disease progression.

# [T] TASK
Determine with urological rigor which patients require a prostate biopsy ('yes') and which do not ('no').
For every decision boundary or patient subgroup, you must weigh:
1. Clinical Severity: Assess the likelihood of harboring undetected clinically significant prostate cancer (csPCa).
2. Prognostic Necessity: Determine if histological tissue confirmation will alter clinical management, or if biopsy is redundant due to already established histopathological malignancy.
3. Risk-Benefit Balance: Weigh procedure risks (sepsis, hematuria, urinary retention, pain, overdiagnosis of indolent disease) against omission risks, ensuring invasive biopsy is recommended only when clinical benefit clearly outweighs procedural harm.







<!-- END_SECTION: human_guidance -->

---

<!-- SECTION: problem_spec -->
### 2. Clinical Problem & Dataset Specification
- **Task**: Binary prostate biopsy recommendation (`biopsy_decision`: 'yes' vs 'no')
- **Partition**: Strictly `split == 'train'` (N = 45 samples)
- **Distribution**: {'yes': 28, 'no': 17} (Initial Root Gini = 0.4701)
- **Clinical Scope**: Official 10 Ground Truth Clinical Variables (EAU / ESMO Guidelines via ChromaDB)
- **Induction Architecture**: Two-Stage Decoupling (Phase A: Variable Prioritization -> Phase B: Boundary Calibration)
- **Constraints**: Impurity reduction Delta Gini > 0.0, Min samples/leaf >= 3, Patience = 5 retries/node, Natural stopping.
<!-- END_SECTION: problem_spec -->

---

<!-- SECTION: active_tree_state -->
```text
├── [NODE: root] radiology_report__pirads <= 3.0 (n=45, Gini=0.4701)
│   ├── [NODE: root_L] structured_prompt__bx == Positive (n=6, Gini=0.2778)
│   │   └── [LEAF: NO] (n=3, Gini=0.4444, dist={'no': 2, 'yes': 1})
│       └── [LEAF: NO] (n=3, Gini=0.0000, dist={'no': 3})
    ├── [NODE: root_R] structured_prompt__bx == Positive (n=39, Gini=0.4260)
    │   ├── [NODE: root_R_L] laboratory_results__psa > 10.0 (n=22, Gini=0.5000)
    │   │   └── [LEAF: NO] (n=5, Gini=0.4800, dist={'no': 3, 'yes': 2})
    │       ├── [NODE: root_R_L_R] radiology_report__psa_density >= 0.2 (n=17, Gini=0.4983)
    │       │   └── [LEAF: YES] (n=6, Gini=0.4444, dist={'yes': 4, 'no': 2})
    │           ├── [NODE: root_R_L_R_R] radiology_report__psa_density >= 0.15 (n=11, Gini=0.4959)
    │           │   └── [LEAF: YES] (n=4, Gini=0.5000, dist={'yes': 2, 'no': 2})
    │               ├── [NODE: root_R_L_R_R_R] structured_prompt__age > 65.0 (n=7, Gini=0.4898)
    │               │   └── [LEAF: NO] (n=3, Gini=0.4444, dist={'no': 2, 'yes': 1})
    │                   └── [LEAF: YES] (n=4, Gini=0.5000, dist={'yes': 2, 'no': 2})
        ├── [NODE: root_R_R] radiology_report__psa_density >= 0.2 (n=17, Gini=0.1107)
        │   └── [LEAF: YES] (n=10, Gini=0.0000, dist={'yes': 10})
            ├── [NODE: root_R_R_R] structured_prompt__age <= 60.0 (n=7, Gini=0.2449)
            │   └── [LEAF: YES] (n=3, Gini=0.4444, dist={'yes': 2, 'no': 1})
                └── [LEAF: YES] (n=4, Gini=0.0000, dist={'yes': 4})

```
<!-- END_SECTION: active_tree_state -->

---

<!-- SECTION: rejected_hypotheses -->
### 4. Rejected Candidate Hypotheses Log
*(No rejected hypotheses yet)*

- **Node 'root' (Attempt 1/3)**: Rule `psa_level > 10.0 (Delta Gini=0.0000)` REJECTED. None

- **Node 'root' (Attempt 1/3)**: Rule `radiology_report__pirads >= 3 (Delta Gini=0.0176)` REJECTED. Split REJECTED: Left partition has 44 samples (Gini=0.4628, dist={'yes': 28, 'no': 16}), Right partition has 1 samples (Gini=0.0, dist={'no': 1}). Impurity reduction Delta Gini = 0.0176 (Parent Gini=0.4701 -> Weighted Child=0.4525).

- **Node 'root' (Attempt 2/3)**: Rule `radiology_report__pirads >= 3 (Delta Gini=0.0176)` REJECTED. Split REJECTED: Left partition has 44 samples (Gini=0.4628, dist={'yes': 28, 'no': 16}), Right partition has 1 samples (Gini=0.0, dist={'no': 1}). Impurity reduction Delta Gini = 0.0176 (Parent Gini=0.4701 -> Weighted Child=0.4525).

- **Node 'root' (Attempt 3/3)**: Rule `radiology_report__pirads >= 3.0 (Delta Gini=0.0176)` REJECTED. Split REJECTED: Left partition has 44 samples (Gini=0.4628, dist={'yes': 28, 'no': 16}), Right partition has 1 samples (Gini=0.0, dist={'no': 1}). Impurity reduction Delta Gini = 0.0176 (Parent Gini=0.4701 -> Weighted Child=0.4525).

- **Node 'root' (Attempt 1/3)**: Rule `PSA > 10.0 (Delta Gini=0.0076)` REJECTED. Split REJECTED: Left partition has 14 samples (Gini=0.4082, dist={'yes': 10, 'no': 4}), Right partition has 31 samples (Gini=0.487, dist={'yes': 18, 'no': 13}). Impurity reduction Delta Gini = 0.0076 (Parent Gini=0.4701 -> Weighted Child=0.4625).

- **Node 'root_L' (Attempt 1/3)**: Rule `radiology_report__psa_density >= 0.15 (Delta Gini=0.0000)` REJECTED. Invalid split: One partition is empty (Left=28, Right=0). Evaluated rule 'radiology_report__psa_density >= 0.15' does not isolate samples in this node. Available values in node partition: [min=0.1508, max=4.097].

- **Node 'root_L' (Attempt 2/3)**: Rule `radiology_report__pirads >= 3.0 (Delta Gini=0.0000)` REJECTED. Invalid split: One partition is empty (Left=28, Right=0). Evaluated rule 'radiology_report__pirads >= 3.0' does not isolate samples in this node. Available values in node partition: [min=3.0, max=5.0].

- **Node 'root_L' (Attempt 3/3)**: Rule `radiology_report__pirads >= 3.0 (Delta Gini=0.0000)` REJECTED. Invalid split: One partition is empty (Left=28, Right=0). Evaluated rule 'radiology_report__pirads >= 3.0' does not isolate samples in this node. Available values in node partition: [min=3.0, max=5.0].

- **Node 'root_R' (Attempt 1/3)**: Rule `radiology_report__psa_density > 0.15 (Delta Gini=0.0000)` REJECTED. Invalid split: One partition is empty (Left=0, Right=17). Evaluated rule 'radiology_report__psa_density > 0.15' does not isolate samples in this node. Available values in node partition: [min=0.01, max=0.14].

- **Node 'root_R_L' (Attempt 1/3)**: Rule `radiology_report__pirads >= 3.0 (Delta Gini=0.0000)` REJECTED. Invalid split: One partition is empty (Left=16, Right=0). Evaluated rule 'radiology_report__pirads >= 3.0' does not isolate samples in this node. Available values in node partition: [min=3.0, max=5.0].

- **Node 'root_R_L' (Attempt 2/3)**: Rule `radiology_report__psa_density >= 0.15 (Delta Gini=0.0000)` REJECTED. Invalid split: One partition is empty (Left=0, Right=16). Evaluated rule 'radiology_report__psa_density >= 0.15' does not isolate samples in this node. Available values in node partition: [min=0.01, max=0.14].

- **Node 'root' (Attempt 1/3)**: Rule `radiology_report__pirads >= 3.0` REJECTED. Invalid split: Child partition has too few samples (Left=44, Right=1, minimum required=3). Evaluated rule 'radiology_report__pirads >= 3.0' creates a degenerate branch. Available values in node partition: [min=2.0, max=5.0].

- **Node 'root' (Attempt 2/3)**: Rule `laboratory_results__psa > 10.0` REJECTED. Split REJECTED: Left partition has 14 samples (Gini=0.4082, dist={'yes': 10, 'no': 4}), Right partition has 31 samples (Gini=0.487, dist={'yes': 18, 'no': 13}). Impurity reduction Delta Gini = 0.0076 (Parent Gini=0.4701 -> Weighted Child=0.4625).

- **Node 'root' (Attempt 3/3)**: Rule `previous_notes__prior_cancer_confirmed == 1` REJECTED. Split REJECTED: Left partition has 5 samples (Gini=0.48, dist={'no': 3, 'yes': 2}), Right partition has 40 samples (Gini=0.455, dist={'yes': 26, 'no': 14}). Impurity reduction Delta Gini = 0.0123 (Parent Gini=0.4701 -> Weighted Child=0.4578).

- **Node 'root_R' (Attempt 1/5)**: Rule `radiology_report__pirads >= 3.0` REJECTED. Invalid split: Child partition has too few samples (Left=16, Right=1, minimum required=3). Evaluated rule 'radiology_report__pirads >= 3.0' creates a degenerate branch. Available values in node partition: [min=2.0, max=5.0].

- **Node 'root_L_L' (Attempt 1/5)**: Rule `radiology_report__pirads >= 4.0` REJECTED. Invalid split: Child partition has too few samples (Left=14, Right=1, minimum required=3). Evaluated rule 'radiology_report__pirads >= 4.0' creates a degenerate branch. Available values in node partition: [min=3.0, max=5.0].

- **Node 'root_L_L' (Attempt 2/5)**: Rule `radiology_report__pirads >= 4.0` REJECTED. Invalid split: Child partition has too few samples (Left=14, Right=1, minimum required=3). Evaluated rule 'radiology_report__pirads >= 4.0' creates a degenerate branch. Available values in node partition: [min=3.0, max=5.0].

- **Node 'root_L_L' (Attempt 3/5)**: Rule `radiology_report__pirads >= 3.0` REJECTED. Invalid split: One partition is empty (Left=15, Right=0). Evaluated rule 'radiology_report__pirads >= 3.0' does not isolate samples in this node. Available values in node partition: [min=3.0, max=5.0].

- **Node 'root_L_L' (Attempt 4/5)**: Rule `radiology_report__pirads >= 4.0` REJECTED. Invalid split: Child partition has too few samples (Left=14, Right=1, minimum required=3). Evaluated rule 'radiology_report__pirads >= 4.0' creates a degenerate branch. Available values in node partition: [min=3.0, max=5.0].

- **Node 'root_L_L' (Attempt 5/5)**: Rule `radiology_report__pirads >= 3.5` REJECTED. Invalid split: Child partition has too few samples (Left=14, Right=1, minimum required=3). Evaluated rule 'radiology_report__pirads >= 3.5' creates a degenerate branch. Available values in node partition: [min=3.0, max=5.0].

- **Node 'root_L_R' (Attempt 1/5)**: Rule `radiology_report__pirads >= 3.0` REJECTED. Invalid split: One partition is empty (Left=13, Right=0). Evaluated rule 'radiology_report__pirads >= 3.0' does not isolate samples in this node. Available values in node partition: [min=3.0, max=5.0].

- **Node 'root_L_R' (Attempt 2/5)**: Rule `radiology_report__pirads >= 4.0` REJECTED. Invalid split: Child partition has too few samples (Left=12, Right=1, minimum required=3). Evaluated rule 'radiology_report__pirads >= 4.0' creates a degenerate branch. Available values in node partition: [min=3.0, max=5.0].

- **Node 'root_L_R' (Attempt 3/5)**: Rule `radiology_report__pirads >= 4.0` REJECTED. Invalid split: Child partition has too few samples (Left=12, Right=1, minimum required=3). Evaluated rule 'radiology_report__pirads >= 4.0' creates a degenerate branch. Available values in node partition: [min=3.0, max=5.0].

- **Node 'root_R_L' (Attempt 1/5)**: Rule `laboratory_results__psa > 10.0` REJECTED. Invalid split: Child partition has too few samples (Left=1, Right=9, minimum required=3). Evaluated rule 'laboratory_results__psa > 10.0' creates a degenerate branch. Available values in node partition: [min=3.5, max=13.2].

- **Node 'root_R_L' (Attempt 2/5)**: Rule `radiology_report__pirads <= 3.0` REJECTED. Invalid split: Child partition has too few samples (Left=2, Right=8, minimum required=3). Evaluated rule 'radiology_report__pirads <= 3.0' creates a degenerate branch. Available values in node partition: [min=3.0, max=5.0].

- **Node 'root_R_L' (Attempt 3/5)**: Rule `radiology_report__pirads >= 3.0` REJECTED. Invalid split: One partition is empty (Left=10, Right=0). Evaluated rule 'radiology_report__pirads >= 3.0' does not isolate samples in this node. Available values in node partition: [min=3.0, max=5.0].

- **Node 'root_R_L' (Attempt 4/5)**: Rule `radiology_report__pirads >= 3.0` REJECTED. Invalid split: One partition is empty (Left=10, Right=0). Evaluated rule 'radiology_report__pirads >= 3.0' does not isolate samples in this node. Available values in node partition: [min=3.0, max=5.0].

- **Node 'root_R_L' (Attempt 5/5)**: Rule `radiology_report__pirads >= 3.0` REJECTED. Invalid split: One partition is empty (Left=10, Right=0). Evaluated rule 'radiology_report__pirads >= 3.0' does not isolate samples in this node. Available values in node partition: [min=3.0, max=5.0].

- **Node 'root_L_R_R' (Attempt 1/5)**: Rule `radiology_report__pirads >= 3.0` REJECTED. Invalid split: One partition is empty (Left=9, Right=0). Evaluated rule 'radiology_report__pirads >= 3.0' does not isolate samples in this node. Available values in node partition: [min=3.0, max=5.0].

- **Node 'root_L_R_R' (Attempt 2/5)**: Rule `structured_prompt__bx == Positive` REJECTED. Invalid split: One partition is empty (Left=0, Right=9). Evaluated rule 'structured_prompt__bx == Positive' does not isolate samples in this node. Available values in node partition: observed categories: ['Negative'].

- **Node 'root_L_R_R' (Attempt 3/5)**: Rule `radiology_report__pirads >= 4.0` REJECTED. Invalid split: Child partition has too few samples (Left=8, Right=1, minimum required=3). Evaluated rule 'radiology_report__pirads >= 4.0' creates a degenerate branch. Available values in node partition: [min=3.0, max=5.0].

- **Node 'root_L_R_R' (Attempt 4/5)**: Rule `radiology_report__pirads >= 4.0` REJECTED. Invalid split: Child partition has too few samples (Left=8, Right=1, minimum required=3). Evaluated rule 'radiology_report__pirads >= 4.0' creates a degenerate branch. Available values in node partition: [min=3.0, max=5.0].

- **Node 'root_R_R' (Attempt 1/5)**: Rule `radiology_report__pirads >= 3.0` REJECTED. Invalid split: Child partition has too few samples (Left=6, Right=1, minimum required=3). Evaluated rule 'radiology_report__pirads >= 3.0' creates a degenerate branch. Available values in node partition: [min=2.0, max=5.0].

- **Node 'root' (Attempt 1/5)**: Rule `radiology_report__pirads >= 3.0` REJECTED. Invalid split: Child partition has too few samples (Left=44, Right=1, minimum required=3). Evaluated rule 'radiology_report__pirads >= 3.0' creates a degenerate branch. Available values in node partition: [min=2.0, max=5.0].

- **Node 'root_R_L' (Attempt 1/5)**: Rule `radiology_report__psa_density >= 3.0` REJECTED. Invalid split: Child partition has too few samples (Left=2, Right=20, minimum required=3). Evaluated rule 'radiology_report__psa_density >= 3.0' creates a degenerate branch. Available values in node partition: [min=0.01, max=4.097].

- **Node 'root_R_L_R' (Attempt 1/5)**: Rule `structured_prompt__bx == Positive` REJECTED. Invalid split: One partition is empty (Left=17, Right=0). Evaluated rule 'structured_prompt__bx == Positive' does not isolate samples in this node. Available values in node partition: observed categories: ['Positive'].

- **Node 'root_R_R' (Attempt 1/5)**: Rule `radiology_report__pirads <= 3.0` REJECTED. Invalid split: One partition is empty (Left=0, Right=17). Evaluated rule 'radiology_report__pirads <= 3.0' does not isolate samples in this node. Available values in node partition: [min=4.0, max=5.0].

- **Node 'root_R_L_R_R' (Attempt 1/5)**: Rule `structured_prompt__bx == Negative` REJECTED. Invalid split: One partition is empty (Left=0, Right=11). Evaluated rule 'structured_prompt__bx == Negative' does not isolate samples in this node. Available values in node partition: observed categories: ['Positive'].

- **Node 'root_R_L_R_R' (Attempt 2/5)**: Rule `radiology_report__psa_density >= 0.2` REJECTED. Invalid split: One partition is empty (Left=0, Right=11). Evaluated rule 'radiology_report__psa_density >= 0.2' does not isolate samples in this node. Available values in node partition: [min=0.01, max=0.1711].

- **Node 'root_R_L_R_R_R' (Attempt 1/5)**: Rule `structured_prompt__bx >= 1.0` REJECTED. None

- **Node 'root_R_L_R_L' (Attempt 1/5)**: Rule `structured_prompt__age <= 67` REJECTED. Split REJECTED: Left partition has 3 samples (Gini=0.4444, dist={'yes': 2, 'no': 1}), Right partition has 3 samples (Gini=0.4444, dist={'yes': 2, 'no': 1}). Impurity reduction Delta Gini = 0.0000 (Parent Gini=0.4444 -> Weighted Child=0.4444).

- **Node 'root_R_L_R_L' (Attempt 2/5)**: Rule `structured_prompt__age <= 3.0` REJECTED. Invalid split: One partition is empty (Left=0, Right=6). Evaluated rule 'structured_prompt__age <= 3.0' does not isolate samples in this node. Available values in node partition: [min=66.0, max=75.0].

- **Node 'root_R_L_R_L' (Attempt 3/5)**: Rule `structured_prompt__age <= 67.0` REJECTED. Split REJECTED: Left partition has 3 samples (Gini=0.4444, dist={'yes': 2, 'no': 1}), Right partition has 3 samples (Gini=0.4444, dist={'yes': 2, 'no': 1}). Impurity reduction Delta Gini = 0.0000 (Parent Gini=0.4444 -> Weighted Child=0.4444).

- **Node 'root_R_L_R_L' (Attempt 4/5)**: Rule `structured_prompt__age <= 67.0` REJECTED. Split REJECTED: Left partition has 3 samples (Gini=0.4444, dist={'yes': 2, 'no': 1}), Right partition has 3 samples (Gini=0.4444, dist={'yes': 2, 'no': 1}). Impurity reduction Delta Gini = 0.0000 (Parent Gini=0.4444 -> Weighted Child=0.4444).

- **Node 'root_R_L_R_L' (Attempt 5/5)**: Rule `structured_prompt__age <= 67` REJECTED. Split REJECTED: Left partition has 3 samples (Gini=0.4444, dist={'yes': 2, 'no': 1}), Right partition has 3 samples (Gini=0.4444, dist={'yes': 2, 'no': 1}). Impurity reduction Delta Gini = 0.0000 (Parent Gini=0.4444 -> Weighted Child=0.4444).
<!-- END_SECTION: rejected_hypotheses -->

---

<!-- SECTION: hypothesis_log -->
### 5. Step-by-Step Multi-Agent Reasoning & Execution Log

#### Turn 2: Split ACCEPTED for Node 'root'
- **Rule**: `radiology_report__psa_density >= 0.15`
- **Literature Citation**: ESMO Clinical Guideline [DIAGNOSIS AND PATHOLOGY] (Risk Assessment) and EAU/ESMO consensus on risk stratification.
- **Clinical Rationale**: The ESMO guidelines recommend using PSA density and the free/total PSA ratio, in conjunction with DRE findings and age, to assess prostate cancer risk. A low free/total PSA ratio (often correlated with a higher PSA density relative to total PSA) is associated with lower risk of clinically significant disease. While the previous rejection focused on absolute PSA values, using the PSA density threshold (e.g., >= 0.15 or similar established cutoffs derived from risk calculators) provides a feature-based split that aligns with evidence-based risk stratification for biopsy indication.
- **Metrics**: Parent Gini=0.4701 -> Weighted Child=0.4422 (Delta Gini = 0.0279)
- **Partitions**: Left (n=28, {'yes': 20, 'no': 8}) | Right (n=17, {'no': 9, 'yes': 8})

#### Turn 7: Split ACCEPTED for Node 'root_R'
- **Rule**: `radiology_report__pirads >= 3.0`
- **Literature Citation**: ESMO Clinical Guideline [DIAGNOSIS AND PATHOLOGY], Section: Staging and Risk Assessment; EAU Clinical Guideline [5.2.4 Imaging]
- **Clinical Rationale**: The split is based on the Prostate Imaging-Reporting and Data System (PI-RADS) score, which is derived from MRI and is a primary tool for risk stratification in prostate cancer management according to ESMO and EAU guidelines. A PI-RADS score of 3 or higher indicates a high probability of clinically significant prostate cancer (csPCa). Since the previous split filtered for low PSA density (<0.15), using the PIRADS score provides an independent, objective measure of lesion aggressiveness that directly informs the decision for targeted biopsy versus omission, aligning with the principle of using imaging to guide biopsy strategy.
- **Metrics**: Parent Gini=0.4983 -> Weighted Child=0.4706 (Delta Gini = 0.0277)
- **Partitions**: Left (n=16, {'yes': 8, 'no': 8}) | Right (n=1, {'no': 1})

#### Turn 10: Split ACCEPTED for Node 'root_R_L'
- **Rule**: `laboratory_results__psa > 10.0`
- **Literature Citation**: ESMO Clinical Guideline [Recommendations] (Topic: biopsy_strategy)
- **Clinical Rationale**: Given the context of prostate cancer risk stratification, and acknowledging that the previous splits filtered for specific imaging parameters (PIRADS >= 3.0), splitting on the absolute PSA level is a fundamental step in risk assessment. The ESMO guidelines explicitly state that the decision to biopsy should be made in light of 'PSA level' alongside other factors like DRE findings, ethnicity, age, and history. A high PSA value (e.g., >10 ng/mL, depending on local context and patient profile) strongly increases the clinical suspicion for clinically significant disease, thus justifying a biopsy when imaging is suggestive.
- **Metrics**: Parent Gini=0.5000 -> Weighted Child=0.4667 (Delta Gini = 0.0333)
- **Partitions**: Left (n=1, {'yes': 1}) | Right (n=15, {'no': 8, 'yes': 7})

#### Turn 1: Split ACCEPTED for Node 'root'
- **Rule**: `radiology_report__psa_density >= 0.15`
- **Literature Citation**: EAU Clinical Guideline [5.2.4 Imaging] (PSA-D cut-off of 0.15 ng/mL/cc)
- **Clinical Rationale**: The split is based on Prostate-Specific Antigen Density (PSA-D), which is the serum PSA divided by prostate volume. The EAU guidelines cite a threshold of 0.15 ng/mL/cc as a key predictor for clinically significant prostate cancer (csPCa) when combined with imaging results. A higher PSA-D suggests a greater likelihood of harboring clinically significant disease, thereby increasing the clinical necessity for targeted biopsy.
- **Metrics**: Parent Gini=0.4701 -> Weighted Child=0.4422 (Delta Gini = 0.0279)
- **Partitions**: Left (n=28, {'yes': 20, 'no': 8}) | Right (n=17, {'no': 9, 'yes': 8})

#### Turn 2: Split ACCEPTED for Node 'root_L'
- **Rule**: `structured_prompt__bx == Positive`
- **Literature Citation**: EAU/ESMO Consensus on Biopsy Strategy and Prior Pathology (Focus on repeat biopsy indications)
- **Clinical Rationale**: The decision to recommend a prostate biopsy is heavily influenced by prior pathological findings. If the patient has a prior confirmed cancer ('Positive' for structured_prompt__bx), the clinical necessity for a repeat biopsy is significantly altered, often shifting the focus from diagnostic confirmation to staging or surveillance based on established pathology. This split separates patients with known malignancy (where biopsy context changes) from those without, allowing for tailored management protocols aligned with EAU/ESMO recommendations regarding repeat biopsies and risk stratification.
- **Metrics**: Parent Gini=0.4082 -> Weighted Child=0.3326 (Delta Gini = 0.0756)
- **Partitions**: Left (n=15, {'yes': 8, 'no': 7}) | Right (n=13, {'yes': 12, 'no': 1})

#### Turn 4: Split ACCEPTED for Node 'root_R'
- **Rule**: `structured_prompt__bx == Positive`
- **Literature Citation**: EAU/ESMO Consensus on Biopsy Strategy and Prior Pathology (Focus on repeat biopsy indications)
- **Clinical Rationale**: Splitting on the prior pathological outcome (`structured_prompt__bx`) is clinically essential. Patients with a prior confirmed cancer ('Positive') require a different management pathway (e.g., staging, surveillance protocols) compared to those without, directly impacting the necessity and interpretation of any subsequent biopsy recommendation. This aligns with guidelines emphasizing individualized risk stratification based on prior pathology.
- **Metrics**: Parent Gini=0.4983 -> Weighted Child=0.4840 (Delta Gini = 0.0143)
- **Partitions**: Left (n=10, {'no': 6, 'yes': 4}) | Right (n=7, {'yes': 4, 'no': 3})

#### Turn 13: Split ACCEPTED for Node 'root_L_R'
- **Rule**: `radiology_report__psa_density >= 0.35`
- **Literature Citation**: ESMO Clinical Guideline [DIAGNOSIS AND PATHOLOGY], Section: Staging and Risk Assessment; EAU Clinical Guideline [5.2.4 Imaging]
- **Clinical Rationale**: The split is based on PSA Density (PSA-D). While the parent node filtered for >= 0.15, splitting further at a higher threshold (e.g., 0.35) leverages the relationship between imaging findings and biochemical markers to refine risk stratification. A higher PSA-D suggests a greater likelihood of clinically significant disease, justifying biopsy when combined with other factors like PI-RADS scores or elevated PSA levels. This rule aims to isolate the subset of patients where the combination of prior filters (low PSA-D) is insufficient to rule out csPCa, necessitating further investigation.
- **Metrics**: Parent Gini=0.1420 -> Weighted Child=0.1367 (Delta Gini = 0.0053)
- **Partitions**: Left (n=4, {'yes': 4}) | Right (n=9, {'yes': 8, 'no': 1})

#### Turn 23: Split ACCEPTED for Node 'root_L_R_R'
- **Rule**: `radiology_report__psa_density >= 0.2`
- **Literature Citation**: ESMO Clinical Guideline [DIAGNOSIS AND PATHOLOGY] (Risk Stratification based on PSA-D)
- **Clinical Rationale**: This split leverages the Prostate-Specific Antigen Density (PSA-D) as a refined risk stratification tool. The threshold of 0.20 ng/ml/cc is chosen to separate patients with higher biochemical risk from those with lower risk, aligning with established guidelines that use PSA density in conjunction with imaging findings (PI-RADS) to guide biopsy decisions. In this specific context, separating the cohort based on a moderate PSA-D threshold allows for the refinement of the decision boundary where prior pathology and MRI scores are already factored in, focusing the remaining uncertainty onto the biochemical risk profile.
- **Metrics**: Parent Gini=0.1975 -> Weighted Child=0.1481 (Delta Gini = 0.0494)
- **Partitions**: Left (n=6, {'yes': 6}) | Right (n=3, {'yes': 2, 'no': 1})

#### Turn 25: Split ACCEPTED for Node 'root_R_R'
- **Rule**: `structured_prompt__bx == Negative`
- **Literature Citation**: EAU/ESMO Consensus on Biopsy Strategy and Prior Pathology (Focus on repeat biopsy indications)
- **Clinical Rationale**: The split is based on the prior pathological outcome (`structured_prompt__bx`). In this specific, highly filtered subset of patients (who have already passed initial screening for low PSA density and are not in a degenerate MRI risk category), separating those with a 'Negative' prior biopsy result from others allows for tailored management. Patients with a prior negative biopsy ('Negative') may be managed under surveillance protocols aligned with EAU/ESMO recommendations for indolent disease, reducing the immediate need for invasive confirmation compared to those with ambiguous or positive prior pathology.
- **Metrics**: Parent Gini=0.4898 -> Weighted Child=0.4047 (Delta Gini = 0.0851)
- **Partitions**: Left (n=4, {'yes': 3, 'no': 1}) | Right (n=3, {'no': 2, 'yes': 1})

#### Turn 2: Split ACCEPTED for Node 'root'
- **Rule**: `radiology_report__pirads <= 3.0`
- **Literature Citation**: EAU/ESMO Guidelines on Prostate Cancer Diagnosis and Management (Imaging Guidance)
- **Clinical Rationale**: The split is based on the PI-RADS score, which is the primary imaging metric for risk stratification. Splitting at PI-RADS 3 separates patients with indeterminate findings (PI-RADS 2 or 3) from those with high probability of clinically significant cancer (PI-RADS 4 or 5). This aligns with clinical practice where biopsy decisions are heavily guided by the MRI results; low suspicion (PI-RADS <= 3) suggests a lower immediate need for invasive confirmation, while high suspicion (PI-RADS > 3) strongly supports proceeding with biopsy to confirm the extent of disease.
- **Metrics**: Parent Gini=0.4701 -> Weighted Child=0.4062 (Delta Gini = 0.0639)
- **Partitions**: Left (n=6, {'no': 5, 'yes': 1}) | Right (n=39, {'yes': 27, 'no': 12})

#### Turn 3: Split ACCEPTED for Node 'root_R'
- **Rule**: `structured_prompt__bx == Positive`
- **Literature Citation**: EAU/ESMO Consensus on Biopsy Strategy and Prior Pathology (Focus on repeat biopsy indications)
- **Clinical Rationale**: Splitting based on the prior histopathological finding ('Positive' for adenocarcinoma) is crucial because it fundamentally alters the clinical necessity of a subsequent prostate biopsy. Patients with a prior confirmed cancer diagnosis ('Positive') are managed under established staging and surveillance protocols, shifting the focus from diagnostic confirmation to definitive treatment planning, thereby reducing the immediate need for invasive re-biopsy unless specific progression or risk changes are identified by imaging or PSA markers.
- **Metrics**: Parent Gini=0.4260 -> Weighted Child=0.3303 (Delta Gini = 0.0957)
- **Partitions**: Left (n=22, {'yes': 11, 'no': 11}) | Right (n=17, {'yes': 16, 'no': 1})

#### Turn 5: Split ACCEPTED for Node 'root_R_L'
- **Rule**: `laboratory_results__psa > 10.0`
- **Literature Citation**: ESMO Recommendations on Biopsy Strategy and Risk Stratification; EAU Guidelines on Prostate Cancer Diagnosis and Management (Biochemical Markers)
- **Clinical Rationale**: In the context of a high-risk subset (PI-RADS > 3.0 and prior pathology), Total Serum PSA serves as a critical biochemical marker for assessing the likelihood of clinically significant prostate cancer (csPCa). A threshold of 10.0 ng/ml is used here to delineate patients with significantly elevated risk, justifying the invasive confirmation (biopsy) when imaging findings are suspicious. This aligns with guidelines that use biochemical markers alongside anatomical and radiological data to guide biopsy decisions in high-risk scenarios.
- **Metrics**: Parent Gini=0.5000 -> Weighted Child=0.4941 (Delta Gini = 0.0059)
- **Partitions**: Left (n=5, {'no': 3, 'yes': 2}) | Right (n=17, {'yes': 9, 'no': 8})

#### Turn 7: Split ACCEPTED for Node 'root_R_L_R'
- **Rule**: `radiology_report__psa_density >= 0.2`
- **Literature Citation**: ESMO Recommendations on Biopsy Strategy and Risk Stratification; EAU Guidelines on Prostate Cancer Diagnosis and Management (Risk Assessment)
- **Clinical Rationale**: In this highly filtered subset of patients (who already have high imaging suspicion and prior pathology), the PSA Density (PSA-D) is used as a biochemical refinement tool for risk stratification. A threshold of 0.20 ng/ml/cc separates patients with a higher likelihood of clinically significant disease from those with lower risk, guiding the decision on whether to proceed with invasive biopsy when other factors are already suggestive. This aligns with guidelines that integrate imaging (PI-RADS) and biochemical markers (PSA-D) for personalized biopsy strategies.
- **Metrics**: Parent Gini=0.4983 -> Weighted Child=0.4777 (Delta Gini = 0.0206)
- **Partitions**: Left (n=6, {'yes': 4, 'no': 2}) | Right (n=11, {'no': 6, 'yes': 5})

#### Turn 9: Split ACCEPTED for Node 'root_R_R'
- **Rule**: `radiology_report__psa_density >= 0.2`
- **Literature Citation**: ESMO Recommendations on Biopsy Strategy and Risk Stratification; EAU Guidelines on Prostate Cancer Diagnosis and Management (Risk Assessment using PSA Density and Imaging Correlation)
- **Clinical Rationale**: In the context of highly suspicious imaging (PI-RADS > 3.0) and prior pathology, PSA Density (PSA-D) is used as a biochemical refinement tool for risk stratification. A threshold of 0.20 ng/ml/cc separates patients with a higher likelihood of harboring clinically significant prostate cancer from those with lower risk. This split refines the decision boundary by isolating the subset where the combination of imaging, prior pathology, and biochemical markers strongly suggests the need for invasive confirmation (biopsy) to assess the extent of disease.
- **Metrics**: Parent Gini=0.1107 -> Weighted Child=0.1008 (Delta Gini = 0.0099)
- **Partitions**: Left (n=10, {'yes': 10}) | Right (n=7, {'yes': 6, 'no': 1})

#### Turn 12: Split ACCEPTED for Node 'root_R_L_R_R'
- **Rule**: `radiology_report__psa_density >= 0.15`
- **Literature Citation**: EAU Clinical Guideline 5.2.4 Imaging; ESMO Recommendations on Biopsy Strategy and Risk Stratification
- **Clinical Rationale**: The split is based on the Prostate-Specific Antigen Density (PSA-D) threshold of 0.15 ng/ml/cc, which is a recognized biochemical marker used in conjunction with imaging to stratify risk for clinically significant prostate cancer (csPCa). In this highly filtered subset (high PI-RADS suspicion and prior pathology), a higher PSA-D suggests a greater likelihood of harboring csPCa, thereby increasing the clinical necessity for invasive confirmation (biopsy) when other factors are already suggestive. This rule refines the decision boundary by isolating patients where biochemical risk is elevated despite imaging context.
- **Metrics**: Parent Gini=0.4959 -> Weighted Child=0.4935 (Delta Gini = 0.0024)
- **Partitions**: Left (n=4, {'yes': 2, 'no': 2}) | Right (n=7, {'no': 4, 'yes': 3})

#### Turn 14: Split ACCEPTED for Node 'root_R_L_R_R_R'
- **Rule**: `structured_prompt__age > 65.0`
- **Literature Citation**: EAU/ESMO Guidelines on Prostate Cancer Diagnosis and Management (Focus on risk stratification and treatment intensity based on patient prognosis).
- **Clinical Rationale**: In the context of high-risk imaging findings (PI-RADS > 3.0) and prior pathology, age serves as a critical prognostic filter. Per EAU/ESMO guidelines, patients with limited life expectancy (typically defined by age thresholds like 65 or 70 years) are often managed under watchful waiting or surveillance protocols to avoid the overtreatment of indolent, non-lethal prostate cancers that would not impact survival. Therefore, setting a threshold at 65 years separates the cohort into those with potentially longer life expectancy (where biopsy might be considered if risk is high) and those with limited prognosis (where omission of invasive biopsy is strongly favored). This rule prioritizes prognostic necessity over diagnostic confirmation when age is advanced.
- **Metrics**: Parent Gini=0.4898 -> Weighted Child=0.4762 (Delta Gini = 0.0136)
- **Partitions**: Left (n=3, {'no': 2, 'yes': 1}) | Right (n=4, {'yes': 2, 'no': 2})

#### Turn 15: Split ACCEPTED for Node 'root_R_R_R'
- **Rule**: `structured_prompt__age <= 60.0`
- **Literature Citation**: EAU/ESMO Guidelines on Prostate Cancer Diagnosis and Management (Focus on risk stratification and treatment intensity based on patient prognosis).
- **Clinical Rationale**: In this highly filtered subset, age is used as a prognostic filter. Patients aged 60 years or younger are generally considered to have a longer life expectancy, allowing for a more cautious approach regarding the potential benefit of invasive biopsy if imaging suspicion is moderate. Conversely, patients older than 60 years (especially those approaching or exceeding 65) often fall into a category where the risk-benefit analysis shifts towards watchful waiting and surveillance, as the likelihood of detecting clinically significant prostate cancer that would impact survival is lower, thereby minimizing the risks associated with overdiagnosis and overtreatment of indolent disease. This aligns with guidelines emphasizing prognostic necessity in older cohorts.
- **Metrics**: Parent Gini=0.2449 -> Weighted Child=0.1905 (Delta Gini = 0.0544)
- **Partitions**: Left (n=3, {'yes': 2, 'no': 1}) | Right (n=4, {'yes': 4})

#### Turn 21: Split ACCEPTED for Node 'root_L'
- **Rule**: `structured_prompt__bx == Positive`
- **Literature Citation**: EAU/ESMO Consensus on Biopsy Strategy and Prior Pathology (Focus on repeat biopsy indications)
- **Clinical Rationale**: Splitting based on the prior histopathological finding ('Positive' for adenocarcinoma) is crucial because it fundamentally alters the clinical necessity of a subsequent prostate biopsy. Patients with a prior confirmed cancer diagnosis are managed under established staging and surveillance protocols, shifting the focus from diagnostic confirmation to definitive treatment planning or risk assessment. This aligns with guidelines emphasizing individualized management based on known pathology, thereby optimizing the risk-benefit balance for invasive testing.
- **Metrics**: Parent Gini=0.2778 -> Weighted Child=0.2222 (Delta Gini = 0.0556)
- **Partitions**: Left (n=3, {'no': 2, 'yes': 1}) | Right (n=3, {'no': 3})
<!-- END_SECTION: hypothesis_log -->

---

<!-- SECTION: final_model_synthesis -->
### 6. Final Model Synthesis & Verification
- **Status**: Induction Complete (Duration: 460.75s, Turns: 22)
- **Total Nodes**: 19
- **Train Accuracy**: 75.56% (34/45)
- **Exported Artifacts**:
  * Topology: `experiments/exp_3/results/artifacts/decision_tree.json`
  * Executable Routine: `experiments/exp_3/results/artifacts/model.py`

```text
├── [NODE: root] radiology_report__pirads <= 3.0 (n=45, Gini=0.4701)
│   ├── [NODE: root_L] structured_prompt__bx == Positive (n=6, Gini=0.2778)
│   │   └── [LEAF: NO] (n=3, Gini=0.4444, dist={'no': 2, 'yes': 1})
│       └── [LEAF: NO] (n=3, Gini=0.0000, dist={'no': 3})
    ├── [NODE: root_R] structured_prompt__bx == Positive (n=39, Gini=0.4260)
    │   ├── [NODE: root_R_L] laboratory_results__psa > 10.0 (n=22, Gini=0.5000)
    │   │   └── [LEAF: NO] (n=5, Gini=0.4800, dist={'no': 3, 'yes': 2})
    │       ├── [NODE: root_R_L_R] radiology_report__psa_density >= 0.2 (n=17, Gini=0.4983)
    │       │   └── [LEAF: YES] (n=6, Gini=0.4444, dist={'yes': 4, 'no': 2})
    │           ├── [NODE: root_R_L_R_R] radiology_report__psa_density >= 0.15 (n=11, Gini=0.4959)
    │           │   └── [LEAF: YES] (n=4, Gini=0.5000, dist={'yes': 2, 'no': 2})
    │               ├── [NODE: root_R_L_R_R_R] structured_prompt__age > 65.0 (n=7, Gini=0.4898)
    │               │   └── [LEAF: NO] (n=3, Gini=0.4444, dist={'no': 2, 'yes': 1})
    │                   └── [LEAF: YES] (n=4, Gini=0.5000, dist={'yes': 2, 'no': 2})
        ├── [NODE: root_R_R] radiology_report__psa_density >= 0.2 (n=17, Gini=0.1107)
        │   └── [LEAF: YES] (n=10, Gini=0.0000, dist={'yes': 10})
            ├── [NODE: root_R_R_R] structured_prompt__age <= 60.0 (n=7, Gini=0.2449)
            │   └── [LEAF: YES] (n=3, Gini=0.4444, dist={'yes': 2, 'no': 1})
                └── [LEAF: YES] (n=4, Gini=0.0000, dist={'yes': 4})

```
<!-- END_SECTION: final_model_synthesis -->
